108 related articles for article (PubMed ID: 10544005)
1. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
Mu Y; Kamada H; Kodaira H; Sato K; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Nov; 264(3):763-7. PubMed ID: 10544005
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice.
Kamada H; Tsutsumi Y; Yamamoto Y; Kihira T; Kaneda Y; Mu Y; Kodaira H; Tsunoda SI; Nakagawa S; Mayumi T
Cancer Res; 2000 Nov; 60(22):6416-20. PubMed ID: 11103807
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood.
Kaneda Y; Yamamoto S; Kihira T; Tsutsumi Y; Nakagawa S; Miyake M; Kawasaki K; Mayumi T
Invasion Metastasis; 1995; 15(3-4):156-62. PubMed ID: 8621271
[TBL] [Abstract][Full Text] [Related]
4. Bioconjugation of laminin peptide YIGSR with poly(styrene co-maleic acid) increases its antimetastatic effect on lung metastasis of B16-BL6 melanoma cells.
Mu Y; Kamada H; Kaneda Y; Yamamoto Y; Kodaira H; Tsunoda S; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Feb; 255(1):75-9. PubMed ID: 10082658
[TBL] [Abstract][Full Text] [Related]
5. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S
Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
[TBL] [Abstract][Full Text] [Related]
6. Amino acids and peptides. XXXIII. A bifunctional poly(ethylene glycol) hybrid of laminin-related peptides.
Maeda M; Kawasaki K; Mu Y; Kamada H; Tsutsumi Y; Smith TJ; Mayumi T
Biochem Biophys Res Commun; 1998 Jul; 248(3):485-9. PubMed ID: 9703952
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
Drug Deliv; 2010; 17(7):541-51. PubMed ID: 20560774
[TBL] [Abstract][Full Text] [Related]
8. Liposomes modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
[TBL] [Abstract][Full Text] [Related]
9. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
10. The use of PVP as a polymeric carrier to improve the plasma half-life of drugs.
Kaneda Y; Tsutsumi Y; Yoshioka Y; Kamada H; Yamamoto Y; Kodaira H; Tsunoda S; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
Biomaterials; 2004 Jul; 25(16):3259-66. PubMed ID: 14980420
[TBL] [Abstract][Full Text] [Related]
11. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
Koliakos KK; Sapountzi Z; Papageorgiou A; Trachana V; Kotsinou S; Koliakos G
In Vivo; 2002; 16(6):511-8. PubMed ID: 12494895
[TBL] [Abstract][Full Text] [Related]
12. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
Yamamura K; Kibbey MC; Jun SH; Kleinman HK
Semin Cancer Biol; 1993 Aug; 4(4):259-65. PubMed ID: 8400148
[TBL] [Abstract][Full Text] [Related]
13. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.
Nomizu M; Yamamura K; Kleinman HK; Yamada Y
Cancer Res; 1993 Aug; 53(15):3459-61. PubMed ID: 8339246
[TBL] [Abstract][Full Text] [Related]
14. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.
Ukawala M; Chaudhari K; Rajyaguru T; Manjappa AS; Murthy RS; Gude R
J Drug Target; 2012 Jan; 20(1):55-66. PubMed ID: 21967151
[TBL] [Abstract][Full Text] [Related]
15. Molecular design of conjugated tumor necrosis factor-alpha: synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis factor-alpha.
Kamada H; Tsutsumi Y; Tsunoda S; Kihira T; Kaneda Y; Yamamoto Y; Nakagawa S; Horisawa Y; Mayumi T
Biochem Biophys Res Commun; 1999 Apr; 257(2):448-53. PubMed ID: 10198233
[TBL] [Abstract][Full Text] [Related]
16. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.
Yoshida N; Ishii E; Nomizu M; Yamada Y; Mohri S; Kinukawa N; Matsuzaki A; Oshima K; Hara T; Miyazaki S
Br J Cancer; 1999 Aug; 80(12):1898-904. PubMed ID: 10471037
[TBL] [Abstract][Full Text] [Related]
17. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells.
Kouzi-Koliakos K; Koliakos G; Trontzos C; Papageorgiou A; Iliadis S; Triantos A; Dimitriadou A; Kanellaki M
Invasion Metastasis; 1996; 16(6):322-9. PubMed ID: 9371232
[TBL] [Abstract][Full Text] [Related]
18. Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression.
Morais Freitas V; Nogueira da Gama de Souza L; Cyreno Oliveira E; Furuse C; Cavalcanti de Araújo V; Gastaldoni Jaeger R
Oral Oncol; 2007 Nov; 43(10):987-98. PubMed ID: 17257887
[TBL] [Abstract][Full Text] [Related]
19. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
20. Amino acids and peptides. XXXI. Preparation of analogs of the laminin-related peptide YIGSR and their inhibitory effect on experimental metastasis.
Maeda M; Izuno Y; Kawasaki K; Kaneda Y; Mu Y; Tsutsumi Y; Nakagawa S; Mayumi T
Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):347-50. PubMed ID: 9501469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
